Related Experiment Video
Updated: Mar 26, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
ADVERSE EVENTS POST-DTAP AND DTwP VACCINATION IN THAI CHILDREN
Insights
Children receiving the whole-cell pertussis (DTwP) vaccine had more early post-vaccination fever than those receiving the acellular pertussis (DTaP) vaccine. However, parental work absence due to vaccination side effects did not significantly differ between the two vaccine types.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Fever is a common adverse event following childhood vaccination.
- Diphtheria-tetanus-whole cell pertussis (DTwP) and diphtheria-tetanus-acellular pertussis (DTaP) vaccines are widely used, with differing reactogenicity profiles.
- Understanding vaccine-related side effects is crucial for parental decision-making and public health strategies.
Purpose of the Study:
- To prospectively compare the incidence of fever within 4 hours post-vaccination.
- To determine the proportion of children developing high fever (≥39°C) after vaccination.
- To evaluate parental work absence due to vaccine-related adverse events.
Main Methods:
- Prospective study of 140 healthy Thai children aged 2 months to 6 years.
- Participants received either DTwP or DTaP vaccine.
- Parents recorded temperature, adverse reactions, and missed workdays in a diary card.
Main Results:
- Twenty children (14.3%) developed fever within 4 hours post-vaccination.
- Higher incidence of early fever in DTwP group (23.6%) compared to DTaP group (4.4%) (p=0.040).
- One child (DTwP) developed high fever; none in the DTaP group (p=0.329). Parental work absence was similar between groups (p=0.059).
Conclusions:
- DTwP vaccine is associated with a higher likelihood of early post-vaccination fever compared to DTaP vaccine.
- No significant difference in parental days missed from work was observed between the DTwP and DTaP vaccine groups.
- These findings can inform healthcare providers and parents when choosing between DTwP and DTaP vaccines.
Abstract:
We conducted a prospective study to compare the development of fever (axillary T ≥ 37.9 °C) within 4 hours of vaccination, determine the proportion of children who develop high fever (T ≥ 39°C) and evaluate parental days missed from work due to their children's vaccination with either the diphtheria-tetanus-whole cell pertussis (DTwP) or diphtheria-tetanus-acellular pertussis (DTaP) vaccine. The results of this study can help physicians and parents decide whether to have their child vaccinated with the DTwP or more expensive DTaP vaccine. We studied 140 healthy Thai children aged 2 months to 6 years from December 2011 to March 2012 who presented for vaccination. Parents recorded their child's temperature, local and systemic adverse reactions and missed days from work due to these adverse events on a diary card. Of the 140 participants, 72 received the DTwP vaccine and 68 received the DTaP vaccine. The median (IQR) age was 4 (2-6) months and the median weight was 7.1 (5.6-8.7) kg. Twenty children developed fever (axillary T ≥ 37.9°C) within 4 hours following vaccination, 17 (23.6%) had received the DTwP vaccine and 3 (4.4%) had received the DTaP vaccine (p = 0.040). One child (1.4%) who had received the DTwP vaccine and none who received the DTaP vaccine developed high fever (T ≥ 39°C) within 4 hours of vaccination (p = 0.329). Parents of two children who received the DTwP vaccine and one child who received the DTaP vaccine missed work following vaccination (p = 0.059). In conclusion, children who received the DTwP vaccines were more likely to have early post-vaccination fever and higher fever but there was no significant difference between the two groups in parental days lost from work.
Related Concept Videos
Diphtheria
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Vaccinations
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Toxicity: Risk factors
Pharmaceutical Poisoning: Potential Scenarios

